Loading…
EpiSante Biomedical specializes in DNA methylation-based cancer detection, offering early screening, post-surgery monitoring, and personalized treatment solutions. The company developed Asia's first liver cancer DNA methylation detection kit and the world's first methylation-based prognostic and ablation monitoring products for liver cancer.
AI named EpiSante Biomedical from February 2026 to March 2026.